BioSpace News Archive

IDEAYA Biosciences, Inc. announced that, on December 28, 2023, the Compensation Committee of IDEAYA’s Board of Directors granted non-qualified stock options to purchase an aggregate of 18,500 shares of the Company’s common stock to a newly hired employee.

Chimerix announced Lisa Decker, Chief Business Officer at IGM Biosciences, has been appointed to Chimerix’s Board of Directors.

Promore Pharma Promore Pharma AB, under change of name to PMD Device Solutions AB, held an extraordinary general meeting on Friday, 29 December 2023.

Virpax® Pharmaceuticals, Inc. announced the results of the Special Meeting of Shareholders held on December 28, 2023.

TiumBio Co., Ltd. announced the completion of a stock financing of 2,320,185 shares of its convertible preferred shares at a price of KRW 8,620 per share in a private placement.

Tenax Therapeutics, Inc. announced that it will be executing a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-80.

SomaLogic, Inc., a leader in proteomics technology, sent the following open letter to stockholders reiterating the Board’s belief that the proposed transaction between SomaLogic and Standard BioTools is in the best interest of all stockholders.

Enveric Biosciences announced it has entered into agreements with certain holders of its existing warrants exercisable for 1,122,000 shares of the Company’s common stock, in the aggregate, to exercise their warrants at a reduced exercise price of $1.37 per share, in exchange for new warrants as described below.

Cell BioEngines, Inc. announced an agreement with Miltenyi to develop and manufacture its expanded hematopoietic stem cell transplantation product for clinical use in hematology-oncology.

Biodexa Pharmaceuticals PLC is pleased to announce the appointment of Ann Merchant to the Board of Directors of the Company as Non-executive Director with effect from 31 December 2023.